ViaLase wins $40M to advance femtosecond laser for glaucoma . 03?Apr?2024 Californian company founded by ophthalmology laser pioneer Tibor Juhasz backed in series C funding round. Glaucoma examination ViaLase , a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40?million in additional finance. Based in Alisa Viejo, between Los Angeles and San Diego, ViaLase says that the cash inje...